Ridaforolimus Eluting Stent System

EluNir™

A pioneer in cardiovascular intervention for 25 years, Medinol raises the bar once again with the introduction of the EluNIR elastomeric Drug-Eluting Stent — a category-of-one innovation purposefully designed to meet the unique demands of the the ever-changing vascular environment.

Dotter has launched this innovative device in the Korean market by acquiring the rights to sell the product from Medinol.

the Ultimate design for Coronary Intervention

  • Improved trackability and pushability for complex and tight lesions with stiffening wire
  • Tapered tip profile for lesion entry
  • Coated shaft provides strong trackability and pushability
  • Excellent visibility with Platinum-Iridum marker
  • 5F and 6F guide catheter compatible
  • Tapered distal shaft for improved trackability and low profile

Get In touch

info@dotter.com

Inquiries about products or suggestions for partnerships
are always welcome

phone  +82.32.258.5448
Fax +82.32.258.5449